Anti-Seizure Drug Levetiracetam Shows Promise in Preventing Alzheimer's Disease
Northwestern University researchers found that levetiracetam, an FDA-approved anti-seizure medication, prevents formation of toxic amyloid-beta 42 peptides in the brain, offering a potential strategy for early Alzheimer's prevention.